The temporal program of peripheral blood gene expression in the response of nonhuman primates to Ebola hemorrhagic fever

Genome Biology

Volumn 8, Issue 8, 2007, Pages

  Rubins, K H Kathleen H ^a,b   Hensley, Lisa E ^c   Wahl Jensen, Victoria ^c   Daddario DiCaprio, Kathleen M ^c   Young, Howard A ^d   Reed, Douglas S ^c   Jahrling, Peter B ^c   Brown, Patrick O ^a   Relman, David A ^a,e   Geisbert, Thomas W ^c  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

^c UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

^e VA PALO ALTO HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAM PROTEIN; ADAM PROTEIN 17; CD68 ANTIGEN; COMPLEMENTARY DNA; CYTOKINE; FAS ASSOCIATED DEATH DOMAIN PROTEIN; FIBRIN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 3; MONOCYTE CHEMOTACTIC PROTEIN 4; PROTEIN BCL X; TOLL LIKE RECEPTOR 1; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; VIRUS DNA; VIRUS GLYCOPROTEIN; ENVELOPE GLYCOPROTEIN, EBOLA VIRUS; INTERFERON; TUMOR NECROSIS FACTOR-ALPHA CONVERTASE; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DNA MICROARRAY; EX VIVO STUDY; FIBRIN DEPOSITION; GENE EXPRESSION SYSTEM; GENETIC TRANSCRIPTION; HOST RESISTANCE; IMMUNE RESPONSE; IN VIVO STUDY; INNATE IMMUNITY; MACACA; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; SIGNAL TRANSDUCTION; VIRUS CELL INTERACTION; VIRUS HEMORRHAGIC FEVER; VIRUS PATHOGENESIS; ANIMAL; BLOOD; GENE EXPRESSION PROFILING; GENETICS; METABOLISM; MONONUCLEAR CELL;

ANIMALIA; EBOLA VIRUS; MARBURGVIRUS; PRIMATES;

ADAM PROTEINS; ANIMALS; APOPTOSIS; FIBRIN; GENE EXPRESSION PROFILING; HEMORRHAGIC FEVER, EBOLA; IMMUNITY, NATURAL; INTERFERONS; LEUKOCYTES, MONONUCLEAR; MACACA FASCICULARIS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; VIRAL ENVELOPE PROTEINS;

EID: 39749089452     PISSN: 14747596     EISSN: 1474760X     Source Type: Journal    
DOI: 10.1186/gb-2007-8-8-r174     Document Type: Article

References (70)

1. Feldmann H Geisbert TW Jahrling PB Klenk HD Netesov SV Peters CJ Sanchez A Swanepoel R Volchkov VE Filoviridae. Virus Taxonomy: VIIIth Report of the International Committee on Taxonomy of Viruses London, UK: Elsevier Academic Press Fauquet CM, Mayo MA, Maniloff J, Desselberger U, Ball LA 2005 645-653
2. Sanchez A Kahn AS ZS R Nabel GL Ksiazek TG Peters CJ Filoviridae. Fields Virology Philadelphia: Lippincott, Williams & Wilkins Knipe DM, Howley PM 2001 1279-1304
3. Jahrling PB Geisbert TW Dalgard DW Johnson ED Ksiazek TG Hall WC Peters CJ Preliminary report: Isolation of Ebola virus from monkeys imported to USA. Lancet 1990 335 502-505 10.1016/0140-6736(90)90737-P 1968529
4. Jahrling PB Geisbert TW Jaax NK Hanes MA Ksiazek TG Peters CJ Experimental infection of cynomolgus macaques with Ebola-Reston filoviruses from the 1989-1990 U.S. epizootic. Arch Virol Suppl 1996 11 115-134 8800793
5. Dalgard DW Hardy RJ Pearson SL Pucak GJ Quander RV Zack PM Peters CJ Jahrling PB Combined simian hemorrhagic fever and Ebola virus infection in cynomolgus monkeys. Lab Anim Sci 1992 42 152-157 1318446
6. Le Guenno B Formentry P Wyers M Gounon P Walker F Boesch C Isolation and partial characterisation of a new strain of Ebola virus. Lancet 1995 345 1271-1274 10.1016/S0140-6736(95)90925-7 7746057
7. Ebola infection in Côte d'Ivoire/Liberia http://www.who.int/csr/ don/1996_01_22c/en/index.html
8. Borio L Inglesby T Peters CJ Schmaljohn AL Hughes JM Jahrling PB Ksiazek T Johnson KM Meyerhoff A O'Toole T et al. Hemorrhagic fever viruses as biological weapons: Medical and public health management. JAMA 2002 287 2391-2405 10.1001/jama.287.18.2391 11988060
9. Stroher U Feldmann H Progress towards the treatment of Ebola haemorrhagic fever. Expert Opin Investig Drugs 2006 15 1523-1535 10.1517/ 13543784.15.12.1523 17107278
10. Hensley LE Jones SM Feldmann H Jahrling PB Geisbert TW Ebola and Marburg viruses: Pathogenesis and development of countermeasures. Curr Mol Med 2005 5 761-772 10.2174/156652405774962344 16375711
11. Feldmann H Jones SM Schnittler HJ Geisbert T Therapy and prophylaxis of Ebola virus infections. Curr Opin Investig Drugs 2005 6 823-830 16121689
12. Villinger F Rollin PE Brar SS Chikkala NF Winter J Sundstrom JB Zaki SR Swanepoel R Ansari AA Peters CJ Markedly elevated levels of interferon (IFN)-gamma, IFN-alpha, interleukin (IL)-2, IL-10, and tumor necrosis factor-alpha associated with fatal Ebola virus infection. J Infect Dis 1999 179 S188-S191 9988183
13. Geisbert TW Young HA Jahrling PB Davis KJ Larsen T Kagan E Hensley LE Pathogenesis of Ebola hemorrhagic fever in primate models: Evidence that hemorrhage is not a direct effect of virus-induced cytolysis of endothelial cells. Am J Pathol 2003 163 2371-2382 1892396 14633609
14. Geisbert TW Hensley LE Larsen T Young HA Reed DS Geisbert JB Scott DP Kagan E Jahrling PB Davis KJ Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: Evidence that dendritic cells are early and sustained targets of infection. Am J Pathol 2003 163 2347-2370 1892369 14633608
15. Zaki SR Goldsmith CS Pathologic features of filovirus infections in humans. Curr Top Microbiol Immunol 1999 235 97-116 9893381
16. Jahrling PB Geisbert J Swearengen JR Jaax GP Lewis T Huggins JW Schmidt JJ LeDuc JW Peters CJ Passive immunization of Ebola virus-infected cynomolgus monkeys with immunoglobulin from hyperimmune horses. Arch Virol Suppl 1996 11 135-140 8800795
17. Fisher-Hoch SP Brammer TL Trappier SG Hutwagner LC Farrar BB Ruo SL Brown BG Hermann LM Perez-Oronoz GI Goldsmith CS et al. Pathogenic potential of filoviruses: Role of geographic origin of primate host and virus strain. J Infect Dis 1992 166 753-763 1527410
18. Geisbert TW Pushko P Anderson K Smith J Davis KJ Jahrling PB Evaluation in nonhuman primates of vaccines against Ebola virus. Emerg Infect Dis 2002 8 503-507 11996686
19. Sullivan NJ Sanchez A Rollin PE Yang ZY Nabel GJ Development of a preventive vaccine for Ebola virus infection in primates. Nature 2000 408 605-609 10.1038/35046108 11117750
20. Rubins KH Hensley LE Jahrling PB Whitney AR Geisbert TW Huggins JW Owen A Leduc JW Brown PO Relman DA The host response to smallpox: Analysis of the gene expression program in peripheral blood cells in a nonhuman primate model. Proc Natl Acad Sci USA 2004 101 15190-15195 523453 15477590 10.1073/pnas.0405759101
21. Jahrling PB Hensley LE Martinez MJ Leduc JW Rubins KH Relman DA Huggins JW Exploring the potential of variola virus infection of cynomolgus macaques as a model for human smallpox. Proc Natl Acad Sci USA 2004 101 15196-15200 523454 15477589 10.1073/pnas.0405954101
22. Boldrick JC Alizadeh AA Diehn M Dudoit S Liu CL Belcher CE Botstein D Staudt LM Brown PO Relman DA Stereotyped and specific gene expression programs in human innate immune responses to bacteria. Proc Natl Acad Sci USA 2002 99 972-977 117415 11805339 10.1073/pnas.231625398
23. Geisbert TW Hensley LE Gibb TR Steele KE Jaax NK Jahrling PB Apoptosis induced in vitro and in vivo during infection by Ebola and Marburg viruses. Lab Invest 2000 80 171-186 10701687
24. Reed DS Hensley LE Geisbert JB Jahrling PB Geisbert TW Depletion of peripheral blood T lymphocytes and NK cells during the course of ebola hemorrhagic Fever in cynomolgus macaques. Viral Immunol 2004 17 390-400 10.1089/vim.2004.17.390 15357905
25. Baize S Leroy EM Georges-Courbot MC Capron M Lansoud-Soukate J Debre P Fisher-Hoch SP McCormick JB Georges AJ Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients. Nat Med 1999 5 423-426 10.1038/7422 10202932
26. Der SD Zhou A Williams BR Silverman RH Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. Proc Natl Acad Sci USA 1998 95 15623-15628 28094 9861020 10.1073/pnas.95.26.15623
27. Boehm U Klamp T Groot M Howard JC Cellular responses to interferon-gamma. Annu Rev Immunol 1997 15 749-795 10.1146/ annurev.immunol.15.1.749 9143706
28. Dolnik O Volchkova V Garten W Carbonnelle C Becker S Kahnt J Stroher U Klenk HD Volchkov V Ectodomain shedding of the glycoprotein GP of Ebola virus. EMBO J 2004 23 2175-2184 424403 15103332 10.1038/sj.emboj.7600219
29. Baize S Leroy EM Georges AJ Georges-Courbot MC Capron M Bedjabaga I Lansoud-Soukate J Mavoungou E Inflammatory responses in Ebola virus-infected patients. Clin Exp Immunol 2002 128 163-168 1906357 11982604 10.1046/j.1365-2249.2002.01800.x
30. Gupta M Mahanty S Ahmed R Rollin PE Monocyte-derived human macrophages and peripheral blood mononuclear cells infected with ebola virus secrete MIP-1alpha and TNF-alpha and inhibit poly-IC-induced IFN-alpha in vitro. Virology 2001 284 20-25 10.1006/viro.2001.0836 11352664
31. Wahl-Jensen V Kurz SK Hazelton PR Schnittler HJ Stroher U Burton DR Feldmann H Role of Ebola virus secreted glycoproteins and virus-like particles in activation of human macrophages. J Virol 2005 79 2413-2419 546544 15681442 10.1128/JVI.79.4.2413-2419.2005
32. Stroher U West E Bugany H Klenk HD Schnittler HJ Feldmann H Infection and activation of monocytes by Marburg and Ebola viruses. J Virol 2001 75 11025-11033 114683 11602743 10.1128/JVI.75.22.11025-11033.2001
33. Hensley LE Young HA Jahrling PB Geisbert TW Proinflammatory response during Ebola virus infection of primate models: Possible involvement of the tumor necrosis factor receptor superfamily. Immunol Lett 2002 80 169-179 10.1016/S0165-2478(01)00327-3 11803049
34. Hutchinson KL Villinger F Miranda ME Ksiazek TG Peters CJ Rollin PE Multiplex analysis of cytokines in the blood of cynomolgus macaques naturally infected with Ebola virus (Reston serotype). J Med Virol 2001 65 561-566 10.1002/jmv.2073 11596094
35. Davis KJ Anderson AO Geisbert TW Steele KE Geisbert JB Vogel P Connolly BM Huggins JW Jahrling PB Jaax NK Pathology of experimental Ebola virus infection in African green monkeys. Involvement of fibroblastic reticular cells. Arch Pathol Lab Med 1997 121 805-819 9278608
36. Jaax NK Davis KJ Geisbert TJ Vogel P Jaax GP Topper M Jahrling PB Lethal experimental infection of rhesus monkeys with Ebola-Zaire (Mayinga) virus by the oral and conjunctival route of exposure. Arch Pathol Lab Med 1996 120 140-155 8712894
37. Geisbert TW Jahrling PB Hanes MA Zack PM Association of Ebola-related Reston virus particles and antigen with tissue lesions of monkeys imported to the United States. J Comp Pathol 1992 106 137-152 10.1016/ 0021-9975(92)90043-T 1597531
38. Schnittler HJ Feldmann H Marburg and Ebola hemorrhagic fevers: Does the primary course of infection depend on the accessibility of organ-specific macrophages? Clin Infect Dis 1998 27 404-406 9709901
39. Bray M Mahanty S Ebola hemorrhagic fever and septic shock. J Infect Dis 2003 188 1613-1617 10.1086/379727 14639530
40. Wahl-Jensen VM Afanasieva TA Seebach J Stroher U Feldmann H Schnittler HJ Effects of Ebola virus glycoproteins on endothelial cell activation and barrier function. J Virol 2005 79 10442-10450 1182673 16051836 10.1128/JVI.79.16.10442-10450.2005
41. Wallach D Varfolomeev EE Malinin NL Goltsev YV Kovalenko AV Boldin MP Tumor necrosis factor receptor and Fas signaling mechanisms. Annu Rev Immunol 1999 17 331-367 10.1146/annurev.immunol.17.1.331 10358762
42. Basler CF Wang X Muhlberger E Volchkov V Paragas J Klenk HD Garcia-Sastre A Palese P The Ebola virus VP35 protein functions as a type I IFN antagonist. Proc Natl Acad Sci USA 2000 97 12289-12294 17334 11027311 10.1073/pnas.220398297
43. Reid SP Leung LW Hartman AL Martinez O Shaw ML Carbonnelle C Volchkov VE Nichol ST Basler CF Ebola virus VP24 binds karyopherin a1 and blocks STAT1 nuclear accumulation. J Virol 2006 80 5156-5167 1472181 16698996 10.1128/JVI.02349-05
44. Basler CF Mikulasova A Martinez-Sobrido L Paragas J Muhlberger E Bray M Klenk HD Palese P Garcia-Sastre A The Ebola virus VP35 protein inhibits activation of interferon regulatory factor 3. J Virol 2003 77 7945-7956 161945 12829834 10.1128/JVI.77.14.7945-7956.2003
45. Mammen EF Disseminated intravascular coagulation (DIC). Clin Lab Sci 2000 13 239-245 11586511
46. Geisbert TW Young HA Jahrling PB Davis KJ Kagan E Hensley LE Mechanisms underlying coagulation abnormalities in ebola hemorrhagic fever: overexpression of tissue factor in primate monocytes/macrophages is a key event. J Infect Dis 2003 188 1618-1629 10.1086/379724 14639531
47. Geisbert TW Hensley LE Jahrling PB Larsen T Geisbert JB Paragas J Young HA Fredeking TM Rote WE Vlasuk GP Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa/tissue factor: A study in rhesus monkeys. Lancet 2003 362 1953-1958 10.1016/S0140-6736(03)15012-X 14683653
48. Volchkova VA Klenk HD Volchkov VE Delta-peptide is the carboxy-terminal cleavage fragment of the nonstructural small glycoprotein sGP of Ebola virus. Virology 1999 265 164-171 10.1006/viro.1999.0034 10603327
49. Volchkova VA Feldmann H Klenk HD Volchkov VE The nonstructural small glycoprotein sGP of Ebola virus is secreted as an antiparallel-orientated homodimer. Virology 1998 250 408-414 10.1006/ viro.1998.9389 9792851
50. Sanchez A Trappier SG Mahy BW Peters CJ Nichol ST The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing. Proc Natl Acad Sci USA 1996 93 3602-3607 39657 8622982 10.1073/pnas.93.8.3602
51. Volchkov VE Becker S Volchkova VA Ternovoj VA Kotov AN Netesov SV Klenk HD GP mRNA of Ebola virus is edited by the Ebola virus polymerase and by T7 and vaccinia virus polymerases. Virology 1995 214 421-430 10.1006/ viro.1995.0052 8553543
52. Volchkov VE Feldmann H Volchkova VA Klenk HD Processing of the Ebola virus glycoprotein by the proprotein convertase furin. Proc Natl Acad Sci USA 1998 95 5762-5767 20453 9576958 10.1073/pnas.95.10.5762
53. Sullivan NJ Peterson M Yang ZY Kong WP Duckers H Nabel E Nabel GJ Ebola virus glycoprotein toxicity is mediated by a dynamin-dependent protein-trafficking pathway. J Virol 2005 79 547-553 538691 15596847 10.1128/JVI.79.1.547-553.2005
54. Simmons G Wool-Lewis RJ Baribaud F Netter RC Bates P Ebola virus glycoproteins induce global surface protein down-modulation and loss of cell adherence. J Virol 2002 76 2518-2528 153797 11836430 10.1128/ jvi.76.5.2518-2528.2002
55. Chan SY Ma MC Goldsmith MA Differential induction of cellular detachment by envelope glycoproteins of Marburg and Ebola (Zaire) viruses. J Gen Virol 2000 81 2155-2159 10950971
56. Yang ZY Duckers HJ Sullivan NJ Sanchez A Nabel EG Nabel GJ Identification of the Ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury. Nat Med 2000 6 886-889 10.1038/78645 10932225
57. Volchkov VE Volchkova VA Muhlberger E Kolesnikova LV Weik M Dolnik O Klenk HD Recovery of infectious Ebola virus from complementary DNA: RNA editing of the GP gene and viral cytotoxicity. Science 2001 291 1965-1969 10.1126/science.1057269 11239157
58. Schnittler HJ Mahner F Drenckhahn D Klenk HD Feldmann H Replication of Marburg virus in human endothelial cells. A possible mechanism for the development of viral hemorrhagic disease. J Clin Invest 1993 91 1301-1309 288099 8473483
59. Liu M Popper SJ Rubins KH Relman DA Early days: Genomics and human responses to infection. Curr Opin Microbiol 2006 9 312-319 10.1016/ j.mib.2006.04.006 16679048
60. Daddario-DiCaprio KM Geisbert TW Stroher U Geisbert JB Grolla A Fritz EA Fernando L Kagan E Jahrling PB Hensley LE et al. Postexposure protection against Marburg haemorrhagic fever with recombinant vesicular stomatitis virus vectors in non-human primates: An efficacy assessment. Lancet 2006 367 1399-1404 10.1016/S0140-6736(06)68546-2 16650649
61. Jahrling PB Geisbert J Swearengen JR Jaax GP Lewis T Huggins JW Schmidt JJ LeDuc JW Peters CJ Passive immunization of Ebola virus-infected cynomolgus monkeys with immunoglobulin from hyperimmune horses. Arch Virol 1996 Suppl 135-140
62. Alizadeh AA Eisen MB Davis RE Ma C Lossos IS Rosenwald A Boldrick JC Sabet H Tran T Yu X et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000 403 503-511 10.1038/35000501 10676951
63. Alizadeh A Eisen M Davis RE Ma C Sabet H Tran T Powell JI Yang L Marti GE Moore DT et al. The lymphochip: A specialized cDNA microarray for the genomic-scale analysis of gene expression in normal and malignant lymphocytes. Cold Spring Harb Symp Quant Biol 1999 64 71-78 10.1101/ sqb.1999.64.71 11232339
64. Brown Lab Protocols http://cmgm.stanford.edu/pbrown/protocols/index.html
65. Eisen MB Brown PO DNA arrays for analysis of gene expression. Methods Enzymol 1999 303 179-205 10349646
66. Perou CM Sorlie T Eisen MB van de Rijn M Jeffrey SS Rees CA Pollack JR Ross DT Johnsen H Akslen LA et al. Molecular portraits of human breast tumours. Nature 2000 406 747-752 10.1038/35021093 10963602
67. Eisen MB Spellman PT Brown PO Botstein D Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 1998 95 14863-14868 24541 9843981 10.1073/pnas.95.25.14863
68. Saldanha AJ Java Treeview: Extensible visualization of microarray data. Bioinformatics 2004 20 3246-3248 10.1093/bioinformatics/bth349 15180930
69. Flohr F Schneider-Schaulies S Haller O Kochs G The central interactive region of human MxA GTPase is involved in GTPase activation and interaction with viral target structures. FEBS Lett 1999 463 24-28 10.1016/S0014-5793(99)01598-7 10601631
70. Jahrling PB Filoviruses and arenaviruses. Manual of Clinical Microbiology Washington, DC: ASM Press Murray PR, Baron EJ, Pfaller M, Tenover FC, Yolken RH 1999 1125-1136